Sepio Capital, LP Bristol Myers Squibb CO Transaction History

Sepio Capital, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $94,673 - $105,119	1,486 Added 4.08%	37,882 $2.42 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $2.06 Million - $2.34 Million	31,375 Added 624.88%	36,396 $2.52 Million
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $1.77 Million - $2.1 Million	-25,860 Reduced 83.74%	5,021 $361,000
Q3 2022 Oct 28, 2022	SELL	$0.13 - $76.84 $622 - $367,986	-4,789 Reduced 13.43%	30,881 $2.2 Million
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $2.59 Million - $2.85 Million	35,670 New	35,670 $2.75 Million
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $1.95 Million - $2.12 Million	-31,441 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $820,494 - $922,813	13,827 Added 78.5%	31,441 $1.99 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $225,532 - $255,569	3,906 Added 28.49%	17,614 $1.09 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $787,250 - $872,377	13,708 New	13,708 $826,000
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $365,978 - $427,864	-6,676 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $20,323 - $29,534	-438 Reduced 6.16%	6,676 $372,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $350,079 - $456,647	7,114 New	7,114 $457,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Sepio Capital, LP with notifications on news.